CT News and Research

RSS

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices.

14 Mar 2014

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced positive top-line results from its pivotal U.S. study.

14 Mar 2014

Roy Castle Lung Cancer Foundation funds two new projects to support research into lung cancer

The Roy Castle Lung Cancer Foundation has funded two new projects at the University of Liverpool which aim to improve survival rates for the UK's biggest cancer killer.

13 Mar 2014

Skip health coverage and the penalty may exceed expectations

The notion that, during its first year, the penalty for not getting health insurance is relatively small is not entirely accurate. News outlets also report on how the health law is affecting retiree health care, insurers' rate-setting processes, pregnant women's coverage and provider networks.

13 Mar 2014

Some states weighing enrollment extension

Several states that are running their own marketplaces and have experienced problems are considering allowing residents more time to sign up for insurance. Also, a number of local news outlets examine their states' enrollment totals released this week by HHS.

13 Mar 2014

MUSC, Alliance Oncology announce strategic radiation therapy affiliation

The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.

12 Mar 2014

FDA clears Toshiba’s CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

12 Mar 2014

Highlights: Calif. insurer satisfaction; Manchin and W. Va. abortion bill; Md. mental health legislation

For the seventh consecutive year, Kaiser Permanente ranked highest in customer satisfaction for health insurance among California policyholders, according to ratings firm J.D. Power & Associates.

12 Mar 2014

Oncologists use mathematical model to develop treatment plans for cancer patients

Physics applies to everything. So when Vittorio Cristini, PhD, started researching cancer, he applied physics. The result he got was a set of mathematical equations that describe, for each person, how many of their tumor cells a cancer treatment could kill.

12 Mar 2014

CT scans predict effectiveness of chemotherapy for pancreatic cancer

Computed tomography (CT) scans routinely taken to guide the treatment of pancreatic cancer may provide an important secondary benefit. According to new research from The University of Texas MD Anderson Cancer Center, the scans also reflect how well chemotherapy will penetrate the tumor, predicting the effectiveness of treatment.

11 Mar 2014

As enrollment deadline looms, subsidies still confuse some consumers

The Wall Street Journal unveils a calculator to help explain these tax credits, or subsidies, while the CT Mirror looks at last-minute consumer questions.

11 Mar 2014

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.

11 Mar 2014

Quality, compliance in post-acute care services becoming fundamental for post-acute care facilities

Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.

10 Mar 2014

3D mammography now available at Lenox Hill Radiology

Lenox Hill Radiology, a wholly owned subsidiary of RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announces that 3D mammography, the latest innovation in breast cancer screening, is now available at its 79th Street location on the Upper West Side.

10 Mar 2014

Who wins and who loses from latest ACA delays?

Media outlets look at the impact of the two-year extension of nonconforming plans, as well as of other regulatory changes that will affect unions and insurers.

10 Mar 2014

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.

6 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

States: Texas GOP rift in primary; L.A. nursing homes scrutiny; Calif. health costs protest

A selection of health policy stories from Texas, California, Arizona, Wisconsin, Connecticut, Virginia and Georgia.

6 Mar 2014

Prehospital stroke alerts can shorten time to emergency treatment

Prehospital stroke alerts by emergency medical services (EMS) personnel can shorten the time to effective treatment with "clot-busting" drugs for patients with stroke, according to a report in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

6 Mar 2014

3.5 million estimated Medicaid signups under health law

Avalere Health projects that of the 8.9 million people "determined eligible" for Medicaid starting last Oct. 1, the number of new enrollees under the health law is likely much smaller -- between 2.4 million and 3.5 million. Other reports look at how health insurance could result in nearly half a million more Americans getting tested for HIV by 2017 -- but how 60,000 people with the virus will be left uninsured in states not expanding Medicaid.

5 Mar 2014

CT News and Research

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Roy Castle Lung Cancer Foundation funds two new projects to support research into lung cancer

Skip health coverage and the penalty may exceed expectations

Some states weighing enrollment extension

MUSC, Alliance Oncology announce strategic radiation therapy affiliation

FDA clears Toshiba’s CT Myocardial Perfusion technology

Highlights: Calif. insurer satisfaction; Manchin and W. Va. abortion bill; Md. mental health legislation

Oncologists use mathematical model to develop treatment plans for cancer patients

CT scans predict effectiveness of chemotherapy for pancreatic cancer

As enrollment deadline looms, subsidies still confuse some consumers

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Quality, compliance in post-acute care services becoming fundamental for post-acute care facilities

3D mammography now available at Lenox Hill Radiology

Who wins and who loses from latest ACA delays?

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

States: Texas GOP rift in primary; L.A. nursing homes scrutiny; Calif. health costs protest

Prehospital stroke alerts can shorten time to emergency treatment

3.5 million estimated Medicaid signups under health law

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News